4.1 Article

Analysis of 43 cases of Langerhans cell histiocytosis (LCH)-induced central diabetes insipidus registered in the JLSG-96 and JLSG-02 studies in Japan

Related references

Note: Only part of the references are listed.
Editorial Material Oncology

Diabetes Insipidus in Langerhans Cell Histiocytosis: When Is Treatment Indicated?

Oussama Abla et al.

PEDIATRIC BLOOD & CANCER (2009)

Article Pediatrics

Pattern and course of neurodegeneration in Langerhans cell histiocytosis

Martha Wnorowski et al.

JOURNAL OF PEDIATRICS (2008)

Review Medicine, General & Internal

Nephrogenic diabetes insipidus

JM Sands et al.

ANNALS OF INTERNAL MEDICINE (2006)

Article Oncology

Risk factors for diabetes insipidus in langerhans cell histiocytosis

N Grois et al.

PEDIATRIC BLOOD & CANCER (2006)

Article Oncology

Cerebellar ataxia in pediatric patients with Langerhans cell histiocytosis

S Imashuku et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY (2004)

Article Endocrinology & Metabolism

Hypopituitarism in Langerhans cell histiocytosis: Seven cases and literature review

D Modan-Moses et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2001)

Article Medicine, General & Internal

Central diabetes insipidus in children and young adults

M Maghnie et al.

NEW ENGLAND JOURNAL OF MEDICINE (2000)